1. HBW Insight
  2. >>Wellness
  3. >>Policy & Regulation

US Formula Industry Gets FTC's Antitrust Attention

Release Of Some Abbott EleCare, Kendmil Import From UK Get FDA OK

 
• By Malcolm Spicer

Chairwoman Lina Khan was careful to note FTC isn’t investigating Abbott Nutrition’s manufacturing practices, its recall of products and shutdown of a plant and the supply shortage that followed.

FTC building, Washinton, DC / USA - April 22 2019: The north facade of the Federal Trade Commission building with carved sculpture above an enterence.
• Source: Shutterstock

The Federal Trade Commission wants to know whether the US infant formula supply shortage is a result of an anticompetitive market as well as whether consumers have encountered unfair or deceptive businesses trying to buy formula.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Compliance

More from Policy & Regulation

Accelerating Natural Options Among US FDA’s Steps For Removing Petroleum-Based Food Dyes

 
• By Malcolm Spicer

HHS Secretary Kennedy commends food companies for cooperating, but also says, “We have them on the run now and we are going to win this battle. And four years from now, we're going to have most of these products off the market.”

US Plans End To Petroleum-Based Dyes In Food

 
• By Malcolm Spicer

HHS Secretary Robet F. Kennedy Jr. and FDA Commissioner Marty Makary to announce planned changes as “a major step forward” as part of Kennedy’s “Make America Healthy Again” campaign President Trump has adopted for his administration.

Deleting Self-Affirmed GRAS Option Could Stretch FDA’s Already Thin Food Safety Resources

 
• By Malcolm Spicer

FDA introduced the option because it didn’t have sufficient staff to handle the volume of GRAS submission reviews requested by food and other firms for ingredients. Requiring submissions for all GRAS determinations “would just be an unworkable situation for the food industry if somehow submitting notice, submitting notices for FDA review and concurrence, was required,” says food and drug attorney Federick Stearns.